Rilonacept Regeneron (previously Arcalyst) - summary of medicine characteristics
Sources: Original PDF (ema.europa.eu)
The drug is classified in the ATC tree:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04AC08 canakinumab
Sources: Original PDF (ema.europa.eu)
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04AC08 canakinumab